Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001939435 | SCV002231178 | pathogenic | not provided | 2024-06-02 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro25Argfs*4) in the OCA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OCA2 are known to be pathogenic (PMID: 19865097, 21541274). This variant is present in population databases (rs747408689, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with OCA2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1454228). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003464297 | SCV004208979 | likely pathogenic | SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES | 2024-03-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005006316 | SCV005630607 | likely pathogenic | Tyrosinase-positive oculocutaneous albinism; SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES | 2024-04-26 | criteria provided, single submitter | clinical testing |